2018 Volume 61 Issue 1 Pages 15-21
A 29-year-old woman was admitted to our hospital due to unconsciousness. She was diagnosed with insulinoma, and distal pancreatectomy was performed. However, her serum chromogranin A (CgA) levels increased after surgery. We therefore examined the patient for metastasis and recurrent insulinoma; but they were not detected. According to previous reports, the serum CgA level in the serum is useful as a diagnostic and follow-up biomarker in cases involving neuroendocrine tumors other than insulinoma. It is more important for clinicians to ask patients about hypoglycemic symptoms and to perform imaging studies when recurrence or metastasis of insulinoma is suspected.